Bryan Kobel

Company: TCBiopharm

Job title: Chief Executive Officer

Seminars:

Panel Discussion: Reflecting on a Year of Industry Advances: Key Insights from 2023 & Anticipating the Path Ahead in 2024 9:00 am

Reviewing latest clinical updates and identifying key areas of growth in the past year Discussing the race to clinic and attracting investors to fund scale ups into the clinic Considering current gamma delta t therapies to drive solid tumor success What does 2024 look like for the field and where is it headed?Read more

day: Conference Day One